Reaction

Hepatorenal Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,674 reports · 64 co-occurring drugs

As of the last recalculation, Hepatorenal Syndrome appears in 1,674 FAERS reports alongside 64 co-occurring drug terms. The strongest observed disproportionality signal is QUININE (PRR 56.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Quinine3856.356.6
Sofosbuvir6643.343.4
Rifaximin5030.630.6
Sorafenib4829.629.6
Ursosiol4328.228.3
Ursodiol4627.027.0
Entecavir2122.622.7
Lactulose6722.622.6
Tolvaptan2319.920.0
Phytonadione1319.219.2
Spironolactone17517.217.2
Velpatasvir And Sofosbuvir1716.616.6
Ribavirin8216.616.6
Propofol4616.116.1
Busulfan2016.016.0
Daspone1215.415.4
Dapsone Gel, 5%1215.415.4
Midazolam Hydrochloride3114.614.6
Diltiazem Hydrochloride Extended-Release Tablets1314.314.3
Dapsone1214.114.1
Midazolam2814.014.0
Moxifloxacin1513.413.4
Budesonide5812.612.7
Lamivudine Oral2512.512.5
Lamivudine3012.312.3
Thiotepa911.811.8
Basiliximab1111.711.7
Propranolol Hydrochloride5710.110.2
Tenofovir Disoproxil Fumarate Tablets710.110.1
Clarithromycin279.99.9
Ledipasvir And Sofosbuvir159.89.8
Rifampin119.49.4
Derma Foam Excel Hand Sanitizer69.49.4
Norepinephrine89.39.4
Ethanol69.39.3
Pegaspargase99.29.2
Raltegravir129.19.1
Mesna Injection69.19.1
Mesna68.98.9
Norepinephrine Bitartrate108.78.7
Rifampicin78.68.6
Brentuximab Vedotin78.58.5
Fentanyl Citrate128.48.4
Cetirizine Hcl68.28.2
Tenofovir Disoproxil Fumarate207.67.6
Meropenem197.47.4
Dronedarone67.37.3
Ritonavir177.37.3
Darunavir86.66.6
Atezolizumab206.56.5
Acetaminophen And Codeine66.16.1
Peginterferon Alfa-2A266.16.1
Gemcitabine196.16.1
Bendamustine Hcl75.65.6
Dolutegravir Sodium45.55.5
Gemcitabine Hydrochloride235.55.5
Doxorubicin375.35.3
Ifosfamide95.25.2
Alcohol154.84.8
Sevoflurane34.54.5
Durvalumab74.34.3
Lenvatinib114.24.2
Ethyl Alcohol94.14.1
Encorafenib33.83.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.